Apnimed, Inc.
NASDAQAPMD short interest falls 29% over one week to 417K shares, with cost to borrow easing to 6.76% amid ample availability at 524% of SI.
Snapshot as of 20 Sept 2026
No long-form analysis yet for APMD. Pulse alerts and the live data picture are available on ORTEX.
Open APMD on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for APMD — free to start on ORTEX.
Sign up for free →Open APMD on ORTEX